88 related articles for article (PubMed ID: 16178123)
1. Reduction of alachlor-induced olfactory mucosal neoplasms by the matrix metalloproteinase inhibitor Ro 28-2653.
Genter MB; Warner BM; Krell HW; Bolon B
Toxicol Pathol; 2005; 33(5):593-9. PubMed ID: 16178123
[TBL] [Abstract][Full Text] [Related]
2. Progression of alachlor-induced olfactory mucosal tumours.
Genter MB; Burman DM; Bolon B
Int J Exp Pathol; 2002 Dec; 83(6):303-8. PubMed ID: 12657139
[TBL] [Abstract][Full Text] [Related]
3. Evolution of alachlor-induced nasal neoplasms in the Long-Evans rat.
Genter MB; Burman DM; Dingeldein MW; Clough I; Bolon B
Toxicol Pathol; 2000; 28(6):770-81. PubMed ID: 11127290
[TBL] [Abstract][Full Text] [Related]
4. Genomic analysis of alachlor-induced oncogenesis in rat olfactory mucosa.
Genter MB; Burman DM; Vijayakumar S; Ebert CL; Aronow BJ
Physiol Genomics; 2002 Dec; 12(1):35-45. PubMed ID: 12419858
[TBL] [Abstract][Full Text] [Related]
5. Evidence for site-specific bioactivation of alachlor in the olfactory mucosa of the Long-Evans rat.
Wetmore BA; Mitchell AD; Meyer SA; Genter MB
Toxicol Sci; 1999 Jun; 49(2):202-12. PubMed ID: 10416265
[TBL] [Abstract][Full Text] [Related]
6. Comparison of rat olfactory mucosal responses to carcinogenic and non-carcinogenic chloracetanilides.
Genter MB; Warner BM; Medvedovic M; Sartor MA
Food Chem Toxicol; 2009 Jun; 47(6):1051-7. PubMed ID: 19425180
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant perturbations in the olfactory mucosa of alachlor-treated rats.
Burman DM; Shertzer HG; Senft AP; Dalton TP; Genter MB
Biochem Pharmacol; 2003 Nov; 66(9):1707-15. PubMed ID: 14563481
[TBL] [Abstract][Full Text] [Related]
8. Strain-specific of alachlor on murine olfactory mucosal responses.
Genter MB; Goss KH; Groden J
Toxicol Pathol; 2004; 32(6):719-25. PubMed ID: 15580706
[TBL] [Abstract][Full Text] [Related]
9. Molecular biology of the nasal airways: how do we assess cellular and molecular responses in the nose?
Genter MB
Toxicol Pathol; 2006; 34(3):274-80. PubMed ID: 16698726
[TBL] [Abstract][Full Text] [Related]
10. Ethane sulfonate metabolite of alachlor: assessment of oncogenic potential based on metabolic and mechanistic considerations.
Heydens WF; Wilson AG; Kraus LJ; Hopkins WE; Hotz KJ
Toxicol Sci; 2000 May; 55(1):36-43. PubMed ID: 10788557
[TBL] [Abstract][Full Text] [Related]
11. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
[TBL] [Abstract][Full Text] [Related]
12. The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model.
Lein M; Jung K; Ortel B; Stephan C; Rothaug W; Juchem R; Johannsen M; Deger S; Schnorr D; Loening S; Krell HW
Oncogene; 2002 Mar; 21(13):2089-96. PubMed ID: 11960381
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer.
Kilian M; Gregor JI; Heukamp I; Hanel M; Ahlgrimm M; Schimke I; Kristiansen G; Ommer A; Walz MK; Jacobi CA; Wenger FA
Prostaglandins Leukot Essent Fatty Acids; 2006 Dec; 75(6):429-34. PubMed ID: 17034997
[TBL] [Abstract][Full Text] [Related]
14. Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats.
Jung K; Krell HW; Ortel B; Hasan T; Römer A; Schnorr D; Loening SA; Lein M
Prostate; 2003 Feb; 54(3):206-11. PubMed ID: 12518325
[TBL] [Abstract][Full Text] [Related]
15. The novel synthetic inhibitor of matrix metalloproteinases Ro 28-2653 induces apoptosis in Dunning tumor cells.
Mangoldt D; Sinn B; Lein M; Krell HW; Schnorr D; Loening SA; Jung K
Apoptosis; 2002 Jun; 7(3):217-20. PubMed ID: 11997665
[TBL] [Abstract][Full Text] [Related]
16. Selective MMP-inhibition with Ro 28-2653 in acute experimental stroke--a magnetic resonance imaging efficacy study.
Nagel S; Heinemann PV; Heiland S; Koziol J; Gardner H; Wagner S
Brain Res; 2011 Jan; 1368():264-70. PubMed ID: 20971083
[TBL] [Abstract][Full Text] [Related]
17. Morphology of nasal lesions induced in Osborne-Mendel rats and B6C3F1 mice by chronic inhalation of allyl glycidyl ether.
Renne RA; Brown HR; Jokinen MP
Toxicol Pathol; 1992; 20(3 Pt 1):416-25. PubMed ID: 1295070
[TBL] [Abstract][Full Text] [Related]
18. Morphology of nasal lesions in F344/N rats following chronic inhalation exposure to naphthalene vapors.
Long PH; Herbert RA; Peckham JC; Grumbein SL; Shackelford CC; Abdo K
Toxicol Pathol; 2003; 31(6):655-64. PubMed ID: 14585734
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 431():1-285. PubMed ID: 12616300
[TBL] [Abstract][Full Text] [Related]
20. Effect of matrix metalloproteinase inhibition on adipose tissue development.
Demeulemeester D; Collen D; Lijnen HR
Biochem Biophys Res Commun; 2005 Apr; 329(1):105-10. PubMed ID: 15721280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
